Currax Pharmaceuticals LLC v. Zydus Pharmaceuticals (USA) Inc. et al
| Currax Pharmaceuticals LLC |
| Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd. |
| 1:2019cv01569 |
| August 23, 2019 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 15, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 STIPULATION TO EXTEND TIME for defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited to answer, plead or otherwise respond to the Complaint (D.I. 1) to December 20, 2019 - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) |
SO ORDERED, re #8 STIPULATION TO EXTEND TIME for defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited to answer, plead or otherwise respond to the Complaint to December 20, 2019 (*Reset Answer Deadlines: Cadila Healthcare Ltd. answer due 12/20/2019; Zydus Pharmaceuticals (USA) Inc. answer due 12/20/2019). Signed by Judge Richard G. Andrews on 10/15/2019. (nms)
|
| Filing 7 WAIVER OF SERVICE returned executed by Currax Pharmaceuticals LLC: For Zydus Pharmaceuticals (USA) Inc. waiver sent on 9/26/2019, answer due 11/25/2019. (Attachments: #1 Certificate of Service)(O'Brien, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Currax Pharmaceuticals LLC: For Cadila Healthcare Ltd. waiver sent on 9/26/2019, answer due 12/26/2019. (Attachments: #1 Certificate of Service)(O'Brien, Daniel) |
| Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Ltd. on 8/30/2019; Zydus Pharmaceuticals (USA) Inc. on 8/30/2019. (nmg) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Currax Holdings USA LLC. for Currax Pharmaceuticals LLC filed by Currax Pharmaceuticals LLC. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,513,299 ;9,107,898 ;9,486,437 ;9,532,971 ;9,861,607 ;9,907,780 ;10,238,620 (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 12, 2019. Date of Expiration of Patent: SEE ATTACHED. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT filed against Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2715393) - filed by Currax Pharmaceuticals LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Civil Cover Sheet)(sam) |
| No Summons Issued. (sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
